Home Authors Posts by Staff Correspondent

Staff Correspondent

416 POSTS 0 COMMENTS
- Advertisement -

Recent Posts

Most Popular

chipotle-cmg-earnings-preview-strong-comp-sales-to-drive-growth-in-q3

Chipotle (CMG) earnings preview: Strong comp sales to drive growth in Q3

Chipotle Mexican Grill (NYSE: CMG) will report earnings results for the third quarter of 2019 on Tuesday, October 22, after the market closes. Analysts estimate earnings of $3.19 per share on revenue of $1.38 billion. Chipotle had a tough time last year with food safety issues but the company seems to have overcome its hurdles.…
currency-headwinds-likely-to-hurt-procter-amp-gamble-pg-q1-earnings

Currency headwinds likely to hurt Procter & Gamble (PG) Q1 earnings

The Procter & Gamble Company (NYSE: PG) is slated to report its first-quarter earnings on Tuesday, October 22, before the market opens. The consumer staples giant will continue to rely on the creation of new innovative products as well as on the continued growth and success of existing brands and products. The results could be…
comps-likely-to-drive-mcdonalds-mcd-q3-earnings-on-oct-22

Comps likely to drive McDonald’s (MCD) Q3 earnings on Oct 22

McDonald’s Corporation (NYSE: MCD) is set to release its third-quarter earnings results on Tuesday before the market opens. Despite foreign currency translation, the fast-food chain’s results will be driven by global same-store sales, which is likely to be positive for the seventeenth consecutive quarter. The average check, traffic, and cash flow per restaurant could be…
tariff-woes-could-hurt-irobot-q3-earnings

Tariff woes could hurt iRobot Q3 earnings

iRobot (NASDAQ: IRBT) is scheduled to report third-quarter 2019 earnings results after the closing bell on Tuesday, October 22. The maker of robotic home appliances is expected to report lower earnings and revenues during the quarter, hurt by headwinds related to the US-China trade tariffs. When the company last reported results in July, it saw…
biogen-biib-earnings-preview-will-stock-bounce-back-after-q3-report

Biogen (BIIB) earnings preview: Will stock bounce back after Q3 report?

The market value of pharma giant Biogen, Inc. (NASDAQ: BIIB) declined by a third in March when the stock suffered a heavy blow after the company discontinued an advanced-stage clinical trial on its Alzheimer’s drug candidate. The stock is yet to recover from the multi-year lows. Biogen is scheduled to release its third-quarter results on…